|
19/12/2008 |
MorphoSys to Effect 1:3 Stock Split on December 23, 2008 |
 |
|
11/12/2008 |
MorphoSys Announces Second Clinical Milestone in Therapeutic Antibody Program |
|
|
10/12/2008 |
MorphoSys Appoints Dr Arndt Schottelius as Chief Development Officer and Member of the Management Board |
|
|
09/12/2008 |
MorphoSys Unveils New Antibody Library, HuCAL PLATINUM® |
|
|
04/12/2008 |
MorphoSys Recognized as Technology Pioneer 2009 by the World Economic Forum |
|
|
26/11/2008 |
MorphoSys and Galapagos Enter Alliance to Co-develop Novel Therapeutic Antibodies in Bone and Joint Disease |
|
|
25/11/2008 |
Key US Patent Granted on Antibodies Against GM-CSF to Treat Inflammatory Disorders |
|
|
18/11/2008 |
MorphoSys and Wacker Intensify Cooperation to Use Wacker Technology for Production of Antibodies |
|
|
13/11/2008 |
MorphoSys Publishes Preclinical Data from MOR103 Program |
|
|
30/10/2008 |
MorphoSys AG Reports Strong Results for the First Nine Months of 2008 - Full Year Profit Guidance Increased |
|
|
29/09/2008 |
Shionogi Extends Research Partnership with MorphoSys |
|
|
24/09/2008 |
MorphoSys Nominates First Pre-Development Program in Antibody Collaboration |
|
